New class of drugs against cancer and inflammation

Kancera invents and develops drugs against life-threatening diseases that currently lack effective treatments, with the main focus on developing drug candidates that work through the so-called the fractal system. Fractalkine is a natural signaling substance that precisely controls both immune cells and cancer cells. Independent research groups have shown that the fractalkine system is a critical factor in the severity of inflammation and cancer development in humans. Kancera is a world leader in the development of small molecule inhibitors of the fractalkine system